Breast Cancer and Immunology

Immunotherapy is the utilization of meds to animate an individual's own invulnerable framework to perceive and obliterate disease cells more viably. Immunotherapy can be utilized to treat a few sorts of breast cancer. A significant piece of the invulnerable framework is its capacity to hold itself back from assaulting typical cells in the body. To do this, it employments "designated spots," which are proteins on resistant cells that should be turned on (or off) to begin an insusceptible reaction. Breast Cancer cells occasionally utilize these designated spots to try not to be assaulted by the insusceptible framework. Medications that focus on these designated spot proteins, help to reestablish the resistant reaction against breast malignancy cells.

  • Pembrolizumab (Keytruda) for breast cancer
  • PD-L1 protein

Related Conference of Breast Cancer and Immunology

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Breast Cancer and Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in